Changzhou Lanling

Changzhou Lanling Pharmaceutical is a China-based pharmaceutical manufacturer specializing in the production of active pharmaceutical ingredients (APIs) and finished dosage forms. Established in 1994, the company operates advanced manufacturing facilities in Changzhou that adhere to international GMP standards. Its core product portfolio focuses on metabolic diseases, cardiovascular health, and anti-infectives, featuring widely used medications such as metformin and gliclazide. Beyond its own product lines, the company provides contract manufacturing (CMO) services to global pharmaceutical partners, leveraging its expertise in chemical synthesis. Lanling Pharmaceutical is committed to delivering high-quality, affordable generic medicines to both domestic and international markets.